Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Biomarker Stories

2013-12-19 23:24:16

The authors of a new study on blood biomarkers and mesothelioma say a panel approach, including several different proteins and glycoproteins, could save lives. Raleigh, NC (PRWEB) December 19, 2013 Surviving Mesothelioma is reporting on newly-published research showing that, in the diagnosis of mesothelioma, more biomarkers are better than one. Writing in a recent issue of Anticancer Research, the scientific team suggests that a glycoprotein called chitinase-3-like-1 (YKL-40) may be an...

2013-12-17 08:29:11

Latest Award Further Demonstrates Company's Established International Intellectual Property Position IRVING, Texas, Dec. 17, 2013 /PRNewswire/ -- Caris Life Sciences(®), a leading biosciences company focused on fulfilling the promise of personalized medicine, has been granted a patent in The People's Republic of China covering its molecular profiling service, Caris Molecular Intelligence(TM), for cancer patients. China represents a large population of unmet medical need, with...

2013-12-13 12:23:46

DUBLIN, Ireland, December 13, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/mrb9sm/global_cancer) has announced the addition of the "Global Cancer Biomarkers Market 2012-2016" [http://www.researchandmarkets.com/research/mrb9sm/global_cancer ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) TechNavio's analysts forecast the Global Cancer Biomarkers...

2013-12-12 20:24:56

Mutational status and protein analysis both key to better understanding possible treatment implications for difficult-to-treat disease IRVING, Texas, Dec. 12, 2013 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, presented a breast cancer study at the 2013 CTCR-AACR San Antonio Breast Cancer Symposium held this week in San Antonio, Texas. The analysis focuses on identifying potentially actionable therapeutic...

2013-12-11 23:25:34

In response to an article published by Medical News Today, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses a new test that may revolutionize the way medical experts diagnose brain cancer. New York, NY (PRWEB) December 11, 2013 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by Medical News Today on November 29th that discusses how a new technique developed...

2013-12-10 12:31:54

PORTLAND, Oregon, December 10, 2013 /PRNewswire/ -- According to a new report titled "Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic Applications and Others) - Global Industry Analysis, Emerging Technologies, Competitive Intelligence, Growth Trends, Size, Share, Opportunities and Forecast, 2013 - 2020" published by Allied Market Research, the global biomarkers...

2013-12-10 08:30:21

An Average of 80 Percent of Adenocarcinoma NSCLC Patients Undergo Testing for Both EGFR-Mutation and ALK-Translocation, According to a New Report from Decision Resources BURLINGTON, Mass., Dec. 10, 2013 /PRNewswire/ -- Decision Resources Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that, in the United States, two-thirds of surveyed U.S. medical oncologists believe that all non-small-cell lung cancer (NSCLC) patients of...

2013-12-09 10:48:55

An international team of scientists led by Fred Hutchinson Cancer Research Center cancer proteomics expert Amanda Paulovich, M.D., has demonstrated the feasibility of large-scale, standardized protein measurements, which are necessary for validation of disease biomarkers and drug targets. The study, to be published Dec. 8 online in the journal Nature Methods, shows that the scientists' targeted protein-detection approach has the potential to systematically and reliably measure the entire...

2013-12-06 23:25:33

The Company’s Cancer Detection Device is a Powerful Portable Laboratory in a Desktop Enclosure Beverly Hills, CA (PRWEB) December 06, 2013 Ancon Technologies, a company devoted to finding new ways to beat cancer, recently unveiled a new cancer-screening device to the public, the NBT detector. The company’s latest product aims to bring cancer detection to the next level: it uses Nanoparticle Biomarker Tagging (NBT) technology to identify cancer biomarkers in exhaled air. According to...

2013-12-06 12:25:19

The Company's Cancer Detection Device is a Powerful Portable Laboratory in a Desktop Enclosure BEVERLY HILLS, Calif., Dec. 6, 2013 /PRNewswire-iReach/ -- Ancon Technologies, a company devoted to finding new ways to beat cancer, recently unveiled a new cancer-screening device to the public, the NBT detector. The company's latest product aims to bring cancer detection to the next level: it uses Nanoparticle Biomarker Tagging (NBT) technology to identify cancer biomarkers in exhaled...